Putri, J. F., Bhargava, P., Dhanjal, J. K., Yaguchi, T., Sundar, D., Kaul, S. C., & Wadhwa, R. (2019). Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers. J Exp Clin Cancer Res.

Putri, Jayarani F., Priyanshu Bhargava, Jaspreet Kaur Dhanjal, Tomoko Yaguchi, Durai Sundar, Sunil C. Kaul, e Renu Wadhwa. "Mortaparib, a Novel Dual Inhibitor of Mortalin and PARP1, Is a Potential Drug Candidate for Ovarian and Cervical Cancers." J Exp Clin Cancer Res 2019.

Putri, Jayarani F., et al. "Mortaparib, a Novel Dual Inhibitor of Mortalin and PARP1, Is a Potential Drug Candidate for Ovarian and Cervical Cancers." J Exp Clin Cancer Res 2019.